Patient Medication Information: uses, side effects, how to take - Apo-Zidovudine-Lamivudine-Nevirapine
ABOUT THIS MEDICATION
What the medication is used for:
The name of your medicine is Apo-Zidovudine-Lamivudine-Nevirapine (zidovudine, lamivudine and nevirapine). Apo-Zidovudine-Lamivudine-Nevirapine is a treatment that contains a combination of three active ingredients that are currently available as separate medicines; zidovudine, lamivudine and nevirapine. Apo-Zidovudine-Lamivudine-Nevirapine is used in the treatment of the Human Immunodeficiency Virus (HIV) infection. HIV infection damages the immune system and can lead to Acquired Immune Deficiency Syndrome (AIDS) and other illnesses. Apo-Zidovudine-Lamivudine-Nevirapine can only be obtained with a prescription from your doctor. You should not be taking zidovudine or lamivudine or nevirapine while taking Apo-Zidovudine-Lamivudine-Nevirapine except during lead in dosing.
What it does:
Apo-Zidovudine-Lamivudine-Nevirapine does not cure HIV or AIDS, and it is not known if it will help you live longer with HIV. People taking Apo-Zidovudine-Lamivudine-Nevirapine may still get infections common in people with HIV (opportunistic infections). Therefore, it is very important that you stay under the care of your doctor.
Apo-Zidovudine-Lamivudine-Nevirapine is a type of anti-HIV medicine called a "non-nucleoside reverse transcriptase inhibitor" (NNRTI). It works by lowering the amount of HIV in the blood ("viral load").
Apo-Zidovudine-Lamivudine-Nevirapine also increases the CD4 cell count in your blood. CD4 cells are a type of white blood cells that are important in helping your body fight infection.
When it should not be used:
- if you have previously demonstrated allergy to any of the components of the product (see What the nonmedicinal ingredients are.).
- If you are allergic (hypersensitive) nevirapine or have used Apo-Zidovudine-Lamivudine-Nevirapine or nevirapine and had a severe rash with associated symptoms such as malaise, fatigue, muscle/joint aches, blisters, facial edema (facial swelling), oral lesions, conjunctivitis, and/or hepatitis, eosinophilia (a lot of white blood cells called eosinophils in the blood), granulocytopenia (a decrease in white blood cells called granulocytes in the blood), lymphadenopathy (swelling of the lymph nodes), and renal dysfunction (kidneys not working properly), you must permanently discontinue Apo-Zidovudine-Lamivudine-Nevirapine or nevirapine and seek medical evaluation immediately. (See WARNINGS AND PRECAUTIONS)
- if you have a severe liver problem
- abnormally low red blood cell count (e.g. anemia) or white blood cell count (e.g. neutropenia).
- do not take Apo-Zidovudine-Lamivudine-Nevirapine with St. John’s wort (Hypericum perforatum) as it will reduce nevirapine blood levels.
The coadministration of Apo-Zidovudine-Lamivudine-Nevirapine with other products containing lamivudine or zidovudine or nevirapine must not be used, except during lead in dosing (see Proper Use of this Medication).
What the medicinal ingredient is:
Each Apo-Zidovudine-Lamivudine-Nevirapine tablet contains 300 mg of zidovudine 150 mg of lamivudine and 200 mg nevirapine.
What the nonmedicinal ingredients are:
Each Apo-Zidovudine-Lamivudine-Nevirapine tablet also contains the non-medicinal ingredients microcrystalline cellulose, methylcellulose, croscarmellose sodium, magnesium stearate and colloidal silicon dioxide.
What dosage forms it comes in:
Each Apo-Zidovudine-Lamivudine-Nevirapine tablet contains 300 mg of zidovudine 150 mg of lamivudine and 200 mg nevirapine.
SERIOUS WARNINGS AND PRECAUTIONS
|
|
In rare cases liver problems have led to liver failure and can lead to a liver transplant or death. Therefore, if you develop any of the following symptoms of liver problems stop taking Apo-Zidovudine-Lamivudine-Nevirapine and call your doctor right away:
- general ill feeling or “flu-like” symptoms
- yellowing skin or whites of your eyes
- tiredness
- dark urine (tea colored)
- nausea (feeling sick to your stomach)
- pale stools (bowel movements)
- lack of appetite
- pain, ache, or sensitivity to touch on your right side below your ribs
Your doctor should check you and do blood tests often to check your liver function during the first 18 weeks of therapy. Checks for liver problems should continue regularly during treatment with Apo-Zidovudine-Lamivudine-Nevirapine.
Skin Reactions
Skin rash is the most common side effect of nevirapine. Most rashes occur in the first 6 weeks of treatment. In a small number of patients, rash can be serious and result in death. Therefore, if you develop a rash with any of the following symptoms stop using Apo-Zidovudine-Lamivudine-Nevirapine and call your doctor right away:
- general ill feeling or “flu-like” symptoms
- blisters
- fever
- mouth sores
- muscle or joint aches
- swelling of your face
- conjunctivitis (red or inflamed eyes, like “pink-eye”)
- tiredness
- any symptoms of liver problems discussed above
If your doctor tells you to stop treatment with Apo-Zidovudine-Lamivudine-Nevirapine because you have experienced the serious liver or skin reactions described above, never take Apo-Zidovudine-Lamivudine-Nevirapine again.
Pancreatitis in Pediatric Patients
In pediatric patients with a history of prior antiretroviral nucleoside exposure, a history of pancreatitis, or other significant risk factors for the development of pancreatitis,
Apo-TriAvi should be used with caution. Treatment with Apo-Zidovudine-Lamivudine-Nevirapine should be stopped immediately if clinical signs, symptoms, or laboratory abnormalities suggestive of pancreatitis occur (see ADVERSE REACTIONS section).
Other special warnings
The class of medicines to which Apo-Zidovudine-Lamivudine-Nevirapine belongs (NRTIs) can cause a condition called lactic acidosis (excess of lactic acid in your blood), together with an enlarged liver.
Symptoms of lactic acidosis include feeling of weakness, loss of appetite, sudden unexplained weight loss, upset stomach and difficulty breathing. This rare but serious side effect occurs more often in women. If you have liver disease you may also be more at risk of getting this condition. While you are being treated with Apo-Zidovudine-Lamivudine-Nevirapine your doctor will monitor you closely for any signs that you may be developing lactic acidosis. See SIDE EFFECTS section for additional information.
If you have hepatitis B infection, you should not stop
Apo-Zidovudine-Lamivudine-Nevirapine without instructions from your doctor, as you may have recurrence of your hepatitis. This may occur due to you suddenly stopping the active substance lamivudine in Apo-Zidovudine-Lamivudine-Nevirapine.
These are not all the side effects of Apo-Zidovudine-Lamivudine-Nevirapine. See the section SIDE EFFECTS AND WHAT TO DO ABOUT THEM for more information. Tell your doctor if you have any side effects from Apo-Zidovudine-Lamivudine-Nevirapine.
BEFORE you use Apo-Zidovudine-Lamivudine-Nevirapine talk to your doctor or pharmacist if:
- You ever had to stop taking this or another medication for this illness because you were allergic to them or they caused problems.
- You have any allergies to foods or drugs.
- You had, or do you have, any diseases of the kidney.
- You had, or do you have, any diseases of the liver, particularly hepatitis B or C infection.
- You had, or do you have, very low red blood cell count (e.g. anemia) or very low white blood cell count (e.g. neutropenia) or any type of blood disorder
- You are pregnant or intend to become pregnant.
- You are breast-feeding or you intend to breast-feed .. It is recommended that HIV infected women not breast-feed, to avoid transmission of the virus to the infant;
- You are taking any medications, including prescription, non-prescription, herbal or homeopathic.
- You are undergoing dialysis.
- You are taking ribavirin as it could cause or worsen anemia (symptoms of tiredness, shortness of breath). Your doctor will advise whether you should stop taking Apo-Zidovudine-Lamivudine-Nevirapine
- You are taking interferon
Remember that treatment with Apo-Zidovudine-Lamivudine-Nevirapine does not reduce the risk of passing the infection onto others. You will still be able to pass HIV by sexual contact or by blood transfusion and you should use appropriate precautions for example:
- Use a condom when you have oral or penetrative sex.
- Don’t risk blood transfer — for example, don’t share needles.
While taking Apo-Zidovudine-Lamivudine-Nevirapine or any other therapy for HIV disease, you may continue to develop other infections and other complications of HIV infection. Therefore, you should keep in regular contact with the doctor who is treating your condition.
Your doctor will arrange regular blood tests to check for side effects. See SIDE EFFECTS section for more details.
Use of This Medicine during Pregnancy and Breast Feeding
If you are pregnant, or planning to become pregnant soon, or if you are breast feeding, you must inform your doctor before taking any medicine, including Apo-Zidovudine-Lamivudine-Nevirapine. The safe use of Apo-Zidovudine-Lamivudine-Nevirapine in pregnancy has not been established. Your doctor will decide whether you should continue to be treated with Apo-Zidovudine-Lamivudine-Nevirapine if you are pregnant. If you take Apo-Zidovudine-Lamivudine-Nevirapine while you are pregnant, talk to your doctor about how you can be included in the Antiretroviral Pregnancy Registry.
Babies and infants exposed to Nucleoside Reverse Transcriptase Inhibitors (NRTIs) during pregnancy or labour, show minor temporary increases in blood levels of lactate. The clinical importance of these temporary increases is unknown.
These findings do not affect the current recommendations to use antiretroviral therapy in pregnant women to prevent transmission of HIV to their babies. There have been very rare reports of disease that affect the neonatal (babies) nervous system such as delayed development and seizures. The long-term effects of Apo-Zidovudine-Lamivudine-Nevirapine are not known.
It is recommended that HIV infected women do not breast feed their infants under any circumstances in order to avoid transmission of HIV from mother to child. The active substances in Apo-Zidovudine-Lamivudine-Nevirapine are likely to be found in breast milk.
You are recommended not to breastfeed your baby while taking Apo-Zidovudine-Lamivudine-Nevirapine.
INTERACTIONS WITH THIS MEDICATION
No drug interaction studies were done for Apo-Zidovudine-Lamivudine-Nevirapine.
Apo-Zidovudine-Lamivudine-Nevirapine may change the effect of other medicines, and other medicines can change the effect of Apo-Zidovudine-Lamivudine-Nevirapine. Tell your doctor about all your medicines, including vitamin supplements, herbal remedies or homeopathic remedies, including those you have bought yourself.
Apo-Zidovudine-Lamivudine-Nevirapine should not be taken with the following drugs:
- boceprevir, delavirdine, efavirenz, elvitegravir (in combination with cobicistat), emtricitabine, etravirine, ketoconazole, ribavirin, rifampin, rilpivirine, stavudine, and zalcitabine.
It is important that you tell your doctor if you are taking any of the medicines below:
- phenytoin, valproic acid,
- oxazepam, lorazepam
- codeine, morphine, methadone
- acetylsalicylic acid, indomethacin, ketoprofen,
- naproxen
- rifampicin, co-trimoxazole (trimethoprim and
- sulfamethoxazole), dapsone, pentamidine
- ganciclovir, fluconazole, amphotericin, flucytosine
- vincristine, vinblastine, doxorubicin
- cimetidine
- probenecid
- clofibrate
- atovaquone, pyrimethamine
- interferon
- Isoprinosine
- fluconazole
- indinavir
- lopinavir/ritonavir combination
- saquinavir
- itraconazole
- clarithromycin to be taken 2 hours before or 2 hours after taking Apo-Zidovudine-Lamivudine-Nevirapine
- fosamprenavir
- tenofovir disoproxil fumarate
- teleprevir
- warfarin
Apo-Zidovudine-Lamivudine-Nevirapine may not be right for you, or you may need careful monitoring.
You should be aware that Apo-Zidovudine-Lamivudine-Nevirapine may change the effectiveness of oral contraceptives. Therefore oral contraceptives and other hormonal methods of birth control should not be used as a method of contraception in women taking Apo-Zidovudine-Lamivudine-Nevirapine; other methods (barrier) must be used.
PROPER USE OF THIS MEDICATION
Usual dose:
Follow the directions exactly as given to you by your doctor or pharmacist regarding the amount and frequency of dosing. The label will usually tell you this information as well. If you are not sure about dosing, ask your doctor or pharmacist.
Adults and Adolescents 15 years of age and older and weighing at least 30 kg:
Initial dose: As a general guide, swallow 1 tablet once a day for the first 14 days with or without food. This reduces the frequency of a rash developing. If a rash develops or you have signs of liver problems (see SIDE EFFECTS) then see your doctor and do not start regular dosing. Your doctor may prescribe other medications during this first 14 days of treatment
- Regular dose: Then take 1 tablet twice daily.
Overdose:
| In case of drug overdosage, contact a healthcare practitioner (e.g. doctor), hospital emergency department or regional Poison Control Centre, even if there are no symptoms. |
Missed Dose:
If you miss a dose: If you forget to take your medicine, take it as soon as you remember. Then continue as before; do not double your next dosage.
If it is almost time for your next dose, do not take the missed dose.
Instead, follow your regular dosing schedule by taking the next dose at its regular time.
If you stop taking Apo-Zidovudine-Lamivudine-Nevirapine for more than 7 days, ask your doctor how much to take before you start taking it again.
Avoid doing things that can spread HIV infection, as Apo-Zidovudine-Lamivudine-Nevirapine does not stop you from passing HIV infection to others. Do not share needles, other injection equipment or personal items that can have blood or body fluids on them, like toothbrushes and razor blades. Always practice safe sex by using a latex or polyurethane condom to lower the chance of sexual contact with semen, vaginal secretions, or blood.
This medicine is for you. Never give it to someone else, as it may harm them even if their symptoms are the same as yours.
Do not change the dose without consulting your doctor.
Also, inform any other doctor, dentist or pharmacist you consult that you are taking this medication.
If you have any other questions about Apo-Zidovudine-Lamivudine-Nevirapine, contact your doctor or pharmacist.
SIDE EFFECTS AND WHAT TO DO ABOUT THEM
Apo-Zidovudine-Lamivudine-Nevirapine can cause serious liver damage and skin reactions that can cause death. Any patients can experience such side effects, but some patients are more at risk than others. See WARNINGS AND PRECAUTIONS.
Other common side effects of nevirapineinclude nausea, fatigue, fever, headache, vomiting, diarrhea, abdominal pain, skin rash and itching, myalgia (muscle pain) and arthralgia (joint pain). This list of side effects is not complete.
Ask your doctor or pharmacist for more information.
Abnormal liver function test results, decrease in red blood cells or white blood cells called granulocytes, decrease in platelets, an increase in certyain liver enzymes, decrease in blood phosphorus, increase in blood pressure amd hypersensitivity including severe allergic reaction with facial swelling may also occur.
If you feel unwell in any other way or have any symptoms that you do not understand, you should contact your doctor immediately.
Sleepiness can occur. Do not drive or operate machinery if you become drowsy.
Changes in body fat have been seen in some patients taking antiretroviral therapy. These changes may include increased amount of fat in the upper back and neck (“buffalo hump”), breasts, and around the trunk. Loss of fat from the legs, arms, and face may also happen. The cause and long-term health effects of these conditions are not known at this time.
Changes in your immune system (Immune Reconstitution Inflammatory Syndrome) can happen when you start taking HIV medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time, or you could develop an autoimmune disease in which your immune system reacts against your own body (e.g. Grave's disease (which affects the thyroid gland), Guillain-Barre syndrome (which affects the nervous system) or polymyositis (which affects the muscles) and it may develop at any time, sometimes months later after the start of HIV therapy). Sometimes symptoms can be severe, so if you develop high temperature (fever), joint or muscle pain, redness, rash, swelling, or fatigue or any new symptoms contact your doctor straight away.
Lactic acidosis is a rare but serious side effect.
Some people taking lamivudine/zidovudine, or other medicines like it (NRTIs), develop a condition called lactic acidosis, together with an enlarged liver.
Lactic acidosis is caused by a build-up of lactic acid in the body. It is rare; if it happens, it usually develops after a few months of treatment. It can be life-threatening, causing failure of internal organs.
Lactic acidosis is more likely to develop in people who have liver disease, especially women.
Signs of lactic acidosis include:
- deep, rapid, difficult breathing
- drowsiness
- numbness or weakness in the limbs
- feeling sick (nausea), being sick (vomiting)
- stomach pain.
During your treatment, your doctor will monitor you for signs of lactic acidosis. If you have any of the symptoms listed above or any other symptoms that worry you:
See your doctor as soon as possible.
Consult your doctor immediately if you experience any symptoms as listed above, or any symptoms that you do not understand.
Always tell your doctor or pharmacist about any undesirable effects you experience after taking Apo-Zidovudine-Lamivudine-Nevirapine, even those not mentioned above.
If you feel unwell in any other way or have any symptoms that you do not understand, you should contact your doctor immediately. Listed below are some side effects that have been noted:
Very common side effects
These may affect more than 1 in 10 people:
- headache
- feeling sick (nausea)
Common side effects
These may affect up to 1 in 10 people:
- being sick (vomiting)
- diarrhea
- stomach pains
- feeling dizzy
- tiredness, lack of energy
- fever (high temperature)
- general feeling of being unwell
- muscle pain and discomfort
- joint pain
- skin rash
- hair loss
Common side effects that may show up in blood tests are:
- a low red blood cell count (anaemia) or low white blood cell count (neutropenia or leucopenia)
- an increase in the level of liver enzymes
- an increased amount in the blood of bilirubin (a substance produced in the liver) which may make your skin appear yellow
- increased levels of lactic acid in the blood.
Uncommon side effects
These may affect up to 1 in 100 people
- shortness of breath
- wind/gas (flatulence)
- itching
muscle weakness
Uncommon side effects that may show up in blood tests are:
- a decrease in the number of cells involved in blood clotting (thrombocytopenia), or in all kinds of blood cells (pancytopenia).
Rare side effects
These may affect up to 1 in 1,000 people
- difficulty in sleeping (insomnia)
- lactic acidosis
- changes in body shape
- liver disorders, such as an enlarged liver or fatty liver
- inflammation of the pancreas (pancreatitis)
- chest pain; disease of the heart muscle (cardiomyopathy)
- fits (convulsions)
- feeling depressed or anxious, not being able to concentrate, feeling drowsy
- indigestion, taste disturbance
- changes in the colour of your nails, your skin, or the skin inside your mouth
- a flu-like feeling — chills and sweating
- loss of appetite
- breakdown of muscle tissue
- passing urine more often
- enlarged breasts in men
- cough
- sweating
- itchy, bumpy rash (hives)
- tingly feelings in the skin (pins and needles)
Rare side effects that may show up in blood tests are:
- increase in an enzyme called amylase
- a failure of the bone marrow to produce new red blood cells (pure red cell aplasia).
Very rare side effects
These may affect up to 1 in 10,000 people
- Damage to nerves (peripheral neuropathy) which may include the following:
- sensation of weakness in the limbs
- numbness
Very rare side effects that may show up in blood tests are:
- a failure of the bone marrow to produce new red or white blood cells (aplastic anaemia).
This is not a complete list of side effects. For any unexpected effects while taking PrApo-Zidovudine-Lamivudine-Nevirapine, contact your doctor or pharmacist.
SERIOUS SIDE EFFECTS: HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM | ||||
|---|---|---|---|---|
| Symptom / effect | Talk with your doctor or pharmacist | Stop taking drugs and seek immediate emergency medical attention | ||
| Only if severe | In all cases | |||
| Comm on | Serious allergic reaction and symptoms of sudden wheeziness and chest pain or tightening, swelling of eyelids, face or lips, skin rash or ‘hives’ anywhere on the body. | |||
| Rare | Pancreatitis (inflammation of the pancreas and symptoms such as nausea, vomiting and severe stomach cramps). | |||
| Lactic acidosis (high level of acid in the blood) and symptoms such as weight loss, fatigue, malaise, abdominal pain, shortness of breath, severe hepatomegaly (swollen liver), with symptoms of liver problems such as nausea, vomiting, abdominal pain, weakness and diarrhea. | ||||
| Unco mmon | Severe liver disease with symptoms such as nausea, abdominal pain, aches, tiredness, lack of appetite, dark urine, pale stools (bowel movement) , yellowing of skin and eyes, and a general ill feeling or “flu-like” symptoms. | |||
Severe skin reactions such as rash, blistering accompanied by symptoms such as fever, muscle/joint pain, tiredness, mouth sores, | ||||
SERIOUS SIDE EFFECTS: HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM |
|---|
| Symptom / effect | Talk with your doctor or pharmacist | Stop taking drugs and seek immediate emergency medical attention |
|---|
| Only if severe | In all cases | |||
|---|---|---|---|---|
swelling of the face, conjunctivitis, and a general ill feeling or “flu-like”symptoms. | ||||
| Blood problems and symptoms such as anemia (lowered red blood cell count) resulting in fatigue, breathlessness, low white blood cell count making you prone to infections. |
HOW TO STORE IT
Store Apo-Zidovudine-Lamivudine-Nevirapine tablets between 15° and 30°C. Protect from light.
As with all medicines, keep Apo-Zidovudine-Lamivudine-Nevirapine out of reach and sight of children.
Do not take your medicine after the expiry date shown on the bottle and the carton.
Reporting Side Effects
You can help improve the safe use of health products for Canadians by reporting serious and unexpected side effects to Health Canada. Your report may help to identify new side effects and change the product safety information. 3 ways to report:
Postage paid labels and the Consumer Side Effect Reporting Form are available at MedEffect. NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice. |
MORE INFORMATION
For more information, please contact your doctor, pharmacist or other healthcare professional.
This leaflet plus the full product monograph, prepared for health professionals, can be obtained by contacting DISpedia, Apotex's Drug Information Service, at 1-800-667-4708.
This leaflet can also be found at: http://www.apotex.ca/products.
Date of Revision: May 30, 2016
